Michael Crompton

Dr. Michael Crompton is a Senior Research Associate at the Bristol Medical School, University of Bristol, focusing on diabetes-related microvascular complications and endothelial glycocalyx preservation. His roles include collaborative research on heparanase inhibition and mineralocorticoid receptor antagonism.

• Key research areas: Diabetes, Glycocalyx, and Mineralocorticoid Receptor mechanisms.
• Active in translational studies linking vascular biology to diabetic nephropathy and cardiovascular disease.

Recent publications highlight his work on therapeutic strategies for microvascular protection, including systemic heparanase inhibitors and receptor antagonists. Collaborations span multidisciplinary teams in pharmacology, biochemistry, and nephrology. His research has garnered significant attention, with open-access publications and citations in major journals.